Chief Executive, ImmPACT Bio
As the chief executive and board director of ImmPACT Bio, Ramachandra leads a team working on developing and commercializing next-generation cell therapies that harness the immune system and address key challenges to current therapeutic approaches in cancer and autoimmune diseases. Prior to joining ImmPACT in November 2021, Ramachandra was the chief science, technology and medical officer for Baxter International, a position he started in June 2017. Ramachandra was also the senior vice president and head of research and development at Pfizer Essential Health.